Literature DB >> 17036307

The muscular Dystrophy Surveillance Tracking and Research Network (MD STARnet): surveillance methodology.

Lisa A Miller1, Paul A Romitti, Christopher Cunniff, Charlotte Druschel, Katherine D Mathews, F John Meaney, Dennis Matthews, Jiji Kantamneni, Zhen-Fang Feng, Nancy Zemblidge, Timothy M Miller, Jennifer Andrews, Deborah Fox, Emma Ciafaloni, Shree Pandya, April Montgomery, Aileen Kenneson.   

Abstract

BACKGROUND: This report focuses on the common protocol developed by the Muscular Dystrophy Surveillance Tracking and Research Network (MD STARnet) for population-based surveillance of Duchenne and Becker muscular dystrophy (DBMD) among 4 states (Arizona, Colorado, Iowa, and New York).
METHODS: The network sites have developed a case definition and surveillance protocol along with software applications for medical record abstraction, clinical review, and pooled data. Neuromuscular specialists at each site review the pooled data to determine if a case meets the case criteria. Sources of potential cases of DBMD include neuromuscular specialty clinics, service sites for children with special healthcare needs, and hospital discharge databases. Each site also adheres to a common information assurance protocol.
RESULTS: A population-based surveillance system for DBMD was created and implemented in participating states.
CONCLUSIONS: The development and implementation of the population-based system will allow for the collection of information that is intended to provide a greater understanding of DBMD prevalence and health outcomes.

Entities:  

Mesh:

Year:  2006        PMID: 17036307      PMCID: PMC5863910          DOI: 10.1002/bdra.20279

Source DB:  PubMed          Journal:  Birth Defects Res A Clin Mol Teratol        ISSN: 1542-0752


  15 in total

1.  A multiple source methodology for the surveillance of fetal alcohol syndrome--The Fetal Alcohol Syndrome Surveillance Network (FASSNet).

Authors:  Karen Hymbaugh; Lisa A Miller; Charlotte M Druschel; Danise W Podvin; F John Meaney; Coleen A Boyle
Journal:  Teratology       Date:  2002

Review 2.  Neonatal screening for muscular dystrophy. Consensus recommendation of the 14th workshop sponsored by the European Neuromuscular Center (ENMC).

Authors:  G J van Ommen; G Scheuerbrandt
Journal:  Neuromuscul Disord       Date:  1993-05       Impact factor: 4.296

3.  Neonatal screening for Duchenne muscular dystrophy: a novel semiquantitative application of the bioluminescence test for creatine kinase in a pilot national program in Cyprus.

Authors:  A Drousiotou; P Ioannou; T Georgiou; E Mavrikiou; G Christopoulos; T Kyriakides; M Voyasianos; A Argyriou; L Middleton
Journal:  Genet Test       Date:  1998

Review 4.  Delayed diagnosis of Duchenne muscular dystrophy.

Authors:  K Mohamed; R Appleton; P Nicolaides
Journal:  Eur J Paediatr Neurol       Date:  2000       Impact factor: 3.140

5.  Genetic epidemiology of Duchenne and Becker muscular dystrophy in Slovenia.

Authors:  B Peterlin; J Zidar; M Meznaric-Petrusa; N Zupancic
Journal:  Clin Genet       Date:  1997-02       Impact factor: 4.438

6.  Prevalence of neuromuscular diseases in Chinese children: a study in southern China.

Authors:  Brian Chung; Virginia Wong; Patrick Ip
Journal:  J Child Neurol       Date:  2003-03       Impact factor: 1.987

7.  The incidence of Duchenne muscular dystrophy in eastern Austria. The controversy regarding CK screening.

Authors:  E Hauser; K Toifl; A Mad; R Bittner
Journal:  Wien Klin Wochenschr       Date:  1993       Impact factor: 1.704

8.  Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals.

Authors:  M Koenig; E P Hoffman; C J Bertelson; A P Monaco; C Feener; L M Kunkel
Journal:  Cell       Date:  1987-07-31       Impact factor: 41.582

9.  Decreased incidence of Duchenne muscular dystrophy in western Japan 1956-1980.

Authors:  K Takeshita; S Kasagi; T Mito; T Tanaka; K Ootani
Journal:  Neuroepidemiology       Date:  1987       Impact factor: 3.282

10.  Duchenne and Becker muscular dystrophy prevalence in South Africa and molecular findings in 128 persons affected.

Authors:  R Ballo; D Viljoen; P Beighton
Journal:  S Afr Med J       Date:  1994-08
View more
  49 in total

1.  Use of complementary and alternative medicine by males with Duchenne or Becker muscular dystrophy.

Authors:  Sarah K Nabukera; Paul A Romitti; Kimberly A Campbell; F John Meaney; Kristin M Caspers; Katherine D Mathews; Stacey M Hockett Sherlock; Soman Puzhankara; Christopher Cunniff; Charlotte M Druschel; Shree Pandya; Dennis J Matthews; Emma Ciafaloni
Journal:  J Child Neurol       Date:  2011-12-07       Impact factor: 1.987

2.  Use of state administrative data sources to study adolescents and young adults with rare conditions.

Authors:  J A Royer; J W Hardin; S McDermott; L Ouyang; J R Mann; O D Ozturk; J Bolen
Journal:  J Gen Intern Med       Date:  2014-08       Impact factor: 5.128

3.  Delayed onset of ambulation in boys with Duchenne muscular dystrophy: Potential use as an endpoint in clinical trials.

Authors:  Jacob J Gissy; Teresa Johnson; Deborah J Fox; Anil Kumar; Emma Ciafaloni; Anthonie J van Essen; Holly L Peay; Ann Martin; Ann Lucas; Richard S Finkel
Journal:  Neuromuscul Disord       Date:  2017-07-21       Impact factor: 4.296

4.  Mutation analysis in a population-based cohort of boys with Duchenne or Becker muscular dystrophy.

Authors:  Christopher Cunniff; Jennifer Andrews; F John Meaney; Katherine D Mathews; Dennis Matthews; Emma Ciafaloni; Timothy M Miller; John B Bodensteiner; Lisa A Miller; Katherine A James; Charlotte M Druschel; Paul A Romitti; Shree Pandya
Journal:  J Child Neurol       Date:  2008-12-12       Impact factor: 1.987

Review 5.  Can outcomes in Duchenne muscular dystrophy be improved by public reporting of data?

Authors:  Michele A Scully; Valerie A Cwik; Bruce C Marshall; Emma Ciafaloni; Jodi M Wolff; Thomas S Getchius; Robert C Griggs
Journal:  Neurology       Date:  2013-02-05       Impact factor: 9.910

6.  Is There a Delay in Diagnosis of Duchenne Muscular Dystrophy Among Preterm-Born Males?

Authors:  Aida Soim; Michael G Smith; Jennifer M Kwon; Joshua R Mann; Shiny Thomas; Emma Ciafaloni
Journal:  J Child Neurol       Date:  2018-05-15       Impact factor: 1.987

7.  Methods for surveillance of fetal alcohol syndrome: The Fetal Alcohol Syndrome Surveillance Network II (FASSNetII) - Arizona, Colorado, New York, 2009 - 2014.

Authors:  Leslie A O'Leary; Linnette Ortiz; April Montgomery; Deborah J Fox; Christopher Cunniff; Margaret Ruttenber; April Breen; Sydney Pettygrove; Don Klumb; Charlotte Druschel; Jaime L Frías; Luther K Robinson; Jacquelyn Bertrand; Kelly Ferrara; Maureen Kelly; Suzanne M Gilboa; F John Meaney
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2015-03-12

8.  Evaluating Implementation of the Updated Care Considerations for Duchenne Muscular Dystrophy.

Authors:  Katherine S Ong; Kathi Kinnett; Rieza Soelaeman; Lauren Webb; Jennifer S Bain; Ann S Martin; Christina Westfield; Julie Bolen; Natalie Street
Journal:  Pediatrics       Date:  2018-10       Impact factor: 7.124

9.  Muscular Dystrophy Surveillance, Tracking, and Research Network pilot: Population-based surveillance of major muscular dystrophies at four U.S. sites, 2007-2011.

Authors:  ThuyQuynh N Do; Natalie Street; Jennifer Donnelly; Melissa M Adams; Christopher Cunniff; Deborah J Fox; Richard O Weinert; Joyce Oleszek; Paul A Romitti; Christina P Westfield; Julie Bolen
Journal:  Birth Defects Res       Date:  2018-08-02       Impact factor: 2.344

10.  Bone Health and Endocrine Care of Boys with Duchenne Muscular Dystrophy: Data from the MD STARnet.

Authors:  David R Weber; Shiny Thomas; Stephen W Erickson; Deborah Fox; Joyce Oleszek; Shree Pandya; Yedatore Venkatesh; Christina Westfield; Emma Ciafaloni
Journal:  J Neuromuscul Dis       Date:  2018
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.